One-year follow-up evaluation of approved Subolesin anti-tick vaccine in Uganda.
Kasaija PD, Kabi F, Semakula J, Kyakuwa I, Contreras M, de la Fuente G, Rutaisire J, Mugerwa S, Gortázar C, de la Fuente J.
Kasaija PD, et al. Among authors: mugerwa s.
Vaccine. 2025 Jan 12;44:126562. doi: 10.1016/j.vaccine.2024.126562. Epub 2024 Nov 29.
Vaccine. 2025.
PMID: 39612805